Evidence map›Paper›PMID 39392151›Full record

ArticleJournal of the American Heart Association2024

Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy.

Luna Cavigli, Gian Luca Ragazzoni, Francesca Vannuccini, Mattia Targetti, Giulia Elena Mandoli, Giada Senesi, Maria Concetta Pastore, Marta Focardi, Matteo Cameli, Serafina Valente and 3 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luna CavigliDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0003-3305-792X
Gian Luca RagazzoniDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0003-2915-0806
Francesca VannucciniDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0009-0008-3629-3884
Mattia TargettiCardiomyopathy Unit Careggi University Hospital Florence Italy.ORCID 0000-0001-9213-8565
Giulia Elena MandoliDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0002-3184-3006
Giada SenesiDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0009-0004-6697-4104
Maria Concetta PastoreDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0002-7223-141X
Marta FocardiDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0002-0879-8526
Matteo CameliDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0003-3872-8964
Serafina ValenteDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.
Marco BonifaziDepartment of Medical Biotechnologies University of Siena Italy.ORCID 0000-0001-6937-9109
Iacopo OlivottoCardiomyopathy Unit Careggi University Hospital Florence Italy.ORCID 0000-0003-1751-9266
Flavio D'AscenziDepartment of Medical Biotechnologies, Sports Cardiology and Rehab Unit University of Siena Italy.ORCID 0000-0002-0947-6836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with hypertrophic cardiomyopathy (HCM) are generally restricted regarding participation in competitive sports based on the potential risk of sudden cardiac death and malignant arrhythmias. As a result, they are often inactive and experience the negative consequences of a sedentary lifestyle. Hence, the need arises to strike the right balance between these 2 extremes through personalized exercise prescription. The aims of this study were (1) to assess the characteristics of patients with HCM practicing regular aerobic physical activity compared with sedentary patients; (2) to perform a personalized moderate-intensity exercise prescription and evaluate its effects. METHODS AND

resultsPatients with HCM were evaluated through clinical assessment, ECG, ambulatory ECG monitoring, echocardiography, and cardiopulmonary testing. A personalized moderate-intensity exercise prescription was performed, and the same investigations were repeated. Physically active patients with HCM demonstrated better cardiopulmonary functional capacity than sedentary patients (oxygen consumption

conclusionsPatients with HCM practicing regular aerobic exercise have a better functional capacity in the absence of relevant events than sedentary patients. Conversely, a sedentary lifestyle led to a deterioration of cardiopulmonary functional capacity and fitness. The tailored moderate-intensity personalized exercise prescription appears to be a feasible approach in carefully selected patients with HCM to counterbalance the negative effects of sedentary behavior without significant major events.

Indexed as

Cardiomyopathy, HypertrophicCardiorespiratory FitnessExercise TherapySedentary BehaviorAdultAgedEchocardiographyElectrocardiography, AmbulatoryExerciseExercise TestExercise ToleranceFemaleHumansMaleMiddle AgedOxygen Consumptioncardiopulmonary functional capacitycardiopulmonary testinghypertrophic cardiomyopathypersonalized exercise prescriptionsedentary lifestyle

Identifiers

PMID39392151
PMCPMC11935575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.